Influenza

A recently created therapy for the influenza virus may help aid in the fight against COVID-19.

The new pathogen panel will distinguish between 20 different common and serious respiratory infections, giving clinicians more confidence in flu season diagnoses.

In a national survey, parents responded they would not be getting a vaccine for their kids during the COVID-19 pandemic.

This test simultaneously detects and differentiates between SARS-CoV-2, influenza A and B.

A new analysis of excess deaths suggests the peak of the current pandemic in New York City had a death rate in the same league as the infamous 1918 influenza pandemic.

A study team examined asthma prevalence in patients hospitalized for COVID-19 with population asthma prevalence and a 4-year average of asthma prevalence in influenza hospitalizations across the United States.

Evidence is accumulating that influenza vaccination protection wanes over the course of a single influenza season, with significant implications for public health.

The pharmaceutical company has over 25% more US doses due to the increased anticipation of higher demand because of COVID-19.

A new survey shows parents’ fears of getting kids to their providers for fear of contracting the virus.

David Ho, MD, likens and contrasts the pandemic to 3 other viral outbreaks and their respective responses.

Manufacturers announce their supplies are being sent out for the upcoming season.

Contracting influenza increased the risk for invasive pneumococcal disease in a study conducted across 3 countries.

A model including clinical symptom reports, Internet searches, and emergency room data predict influenza hospitalizations better in affluent vs. poorer communities.

New study findings shed light on the positive effects of baloxavir for preventing influenza spread in household settings.

With the current COVID-19 outbreak, new data about Influenza mortality related to spectator sports should make the professional leagues and fans pause about attending games.

Baloxavir marboxil showed superiority over placebo and similar efficacy to oseltamir in reducing influenza symptoms.

While COVID-19 may have impacted flu-like illness reporting, the CDC estimates there were between 24,000-62,000 related deaths this year.

Experts argue that though public officials may liken coronavirus to "just another flu," the true numbers show a stark difference.

It is known that the type of respiratory specimen, sampling environmental factors, and time from symptom onset impact the sensitivity of rapid influenza diagnostic tests.

Flu burden for children can be reduced by improving adherence to a 2-dose series of flu vaccinations.

A team of investigators lay out 3 scenarios for the global pandemic duration—based on previous pandemic learning and public health adherence.

As the influenza season for 2019-20 comes to a close, Contagion® has the latest on baloxavir and what other infections adults with the flu may have.

Investigators performed avian influenza surveillance in wild bird gatherings across China between 2017 through 2019, isolating and exploring the biological characteristics of 2 different H16N3 subtype influenza viruses.

CDC investigators believe they have determined the cause for influenza vaccine effectiveness decline.

Learn what Cidara Therapeutics has in development in this episode of Contagion® Connect.